fbpx

Robbins Arroyo LLP: Trevena, Inc. (TRVN) Misled Shareholders According to a Class Action

SAN DIEGO & CHESTERBROOK, Pa.–(BUSINESS WIRE)–$TRVN #Lawsuit–Shareholder rights law firm Robbins
Arroyo LLP
announces that purchasers of Trevena, Inc. (NasdaqGS:
TRVN) have filed a class action complaint against the company’s officers
and directors for alleged violations of the Securities Exchange Act of
1934 between May 2, 2016 and October 8, 2018. Trevena, a
biopharmaceutical company, develops therapies based on breakthrough
science to benefit patients and healthcare providers confronting serious
medical conditions. Trevena’s product candidate, known as oliceridine,
is designed to treat pain intravenously.

View this information on the law firm’s Shareholder Rights Blog: https://www.robbinsarroyo.com/trevena-inc/

Trevena Accused of Lying to Investors About Critical FDA Meeting
for Over Two Years

According to the complaint, Trevena led shareholders to believe that the
company’s April 2016 End-of-Phase 2 meeting with the U.S. Food and Drug
Administration (“FDA”) was more successful than it actually was. Trevena
stated that it had reached an agreement with the FDA on key elements of
its Phase 3 program for oliceridine and that the company was “very
pleased” with the outcome. However, on October 9, 2018, two days before
Trevena’s meeting with the FDA to discuss whether oliceridine would be
approved for commercial use, the FDA released meeting minutes from the
April 2016 meeting revealing that the FDA did not agree
with the proposed dosing in the Phase 3 studies, among other things. On
this news, Trevena’s stock plummeted 64% to close at $1.07 per share on
October 9, 2018, and continues to decline.

Trevena Shareholders Have Legal Options

Concerned shareholders who would like more information about their
rights and potential remedies can contact attorney Leonid Kandinov at
(800) 350-6003, [email protected],
or via the shareholder
information form
on the firm’s website.

Robbins Arroyo LLP is a nationally recognized leader in shareholder
rights law. The firm represents individual and institutional investors
in shareholder derivative and securities class action lawsuits, and has
helped its clients realize more than $1 billion of value for themselves
and the companies in which they have invested. Sign up for our FREE
portfolio monitoring service, Stock
Watch
.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Robbins Arroyo LLP
Leonid Kandinov
(619) 525-3990 or Toll Free
(800) 350-6003
[email protected]
www.robbinsarroyo.com

leverton

Content is the most important part of having quality links to your website. With Area-Info.net, we provide a quality location to share your story and include links to your website to help you grow. If you would like to learn more, visit this page to see how you can use Area-Info.net to rank higher and quicker in search engines. Contact me directly at [email protected] with any questions, or to schedule speaking engagements.